Peripheral Artery Disease News and Research

RSS
Peripheral arterial disease (PAD) occurs when leg arteries become narrowed or blocked by plaque. These blockages can result in severe pain for patients, limited physical mobility, and life-threatening non-healing leg ulcers. According to the American Heart Association, this condition affects approximately 8 to 12 million Americans. With only about 25 percent of PAD patients undergoing treatment, it is a disease that is largely under-diagnosed and under-treated. If left untreated, PAD can lead to critical leg ischemia, a condition where not enough blood is being delivered to the leg to keep the tissue alive. Total loss of circulation to the legs and feet can cause gangrene and lead to amputation.
FSS’ FlexStent Iliac system receives CE Mark

FSS’ FlexStent Iliac system receives CE Mark

Femoropopliteal total occlusion therapy advances

Femoropopliteal total occlusion therapy advances

Four live cases using Toshiba's Infinix-i vascular X-ray systems to be showcased at NCVH

Four live cases using Toshiba's Infinix-i vascular X-ray systems to be showcased at NCVH

Multiple companies receive FDA approval to sell generic Plavix

Multiple companies receive FDA approval to sell generic Plavix

Boston Scientific launches Innova Self-Expanding Bare-Metal Stent System in Europe

Boston Scientific launches Innova Self-Expanding Bare-Metal Stent System in Europe

Two types of stent systems are both effective in treating iliac artery disease

Two types of stent systems are both effective in treating iliac artery disease

Resverlogix completes RVX-208 Phase 2b trial on CVD

Resverlogix completes RVX-208 Phase 2b trial on CVD

ENABLER-P Balloon Catheter System offers alternative to surgical revascularization

ENABLER-P Balloon Catheter System offers alternative to surgical revascularization

Study investigates use of stem cells to treat lower-limb peripheral artery disease

Study investigates use of stem cells to treat lower-limb peripheral artery disease

FDA clears Angioslide’s new 3X100mm PROTEUS device

FDA clears Angioslide’s new 3X100mm PROTEUS device

Depression may increase risk of peripheral artery disease

Depression may increase risk of peripheral artery disease

Autologous BMMNCs reduce vascular growth in patients with diabetes

Autologous BMMNCs reduce vascular growth in patients with diabetes

Medtronic plans IN.PACT Global drug-eluting balloon SFA clinical study

Medtronic plans IN.PACT Global drug-eluting balloon SFA clinical study

Intact Vascular’s Tack-it Endovascular Stapler device receives CE Mark approval

Intact Vascular’s Tack-it Endovascular Stapler device receives CE Mark approval

NINDS awards NeuroSigma Phase I grant to develop TFN-covered stents

NINDS awards NeuroSigma Phase I grant to develop TFN-covered stents

Vermillion fourth quarter total revenues increase 152% to $868,000

Vermillion fourth quarter total revenues increase 152% to $868,000

New embolization procedure may bring hope to men with enlarged prostate

New embolization procedure may bring hope to men with enlarged prostate

Vascular Magnetics to advance development of new drug delivery system for PAD

Vascular Magnetics to advance development of new drug delivery system for PAD

Screening events to find out risk for heart attack or stroke

Screening events to find out risk for heart attack or stroke

Novel stem-cell technique to enhance bone growth

Novel stem-cell technique to enhance bone growth

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.